TNFRSF9 and neoplasm: Tumor-infiltrating T-cells demonstrated an activated phenotype as detected by increased expression of 4-1BB (CD137), an activation-induced T-cell costimulatory molecule (47), and PD-1, a hallmark of T-cell activation in this context (Figure 1D).